Diabetes

Key opinion leaders discuss the role of combination therapies in the management of diabetes.

Managing hypertension is a critical aspect of diabetes disease management.

A review showed lifestyle intervention was linked to a 24% reduction in type 2 diabetes (T2D) incidence among women with prior gestational diabetes, compared with standard of care.

The panel shares insights into the evolution of treatment strategies for patients with diabetes.

A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.

With data collection beginning on January 1, 2023, most health systems are not prepared for CMS’ new glycemia measures, and those that are will likely be floored by the results, according to the chief medical officer at Glytec.

The top 5 most listened to podcast episodes on AJMC.com in 2022 provided expert commentary on diabetes, lung disease, health policy, Parkinson disease, and more.

The top 5 most-read articles about diabetes featured stories on FDA approvals, drug prices, and the effectiveness of vitamin D in diabetes prevention, among others.

The new federal spending bill includes changes to Medicaid enrollment, postpartum coverage, and other health programs; new research shows widened disparities among US adults with diabetes using insulin; in 2022, the Drug Enforcement Administration confiscated more than 379 million fentanyl doses.

A new study has found that Mexican Americans and non-Hispanic Black Americans had low rates of glycemic control compared with non-Hispanic White Americans.

The staff clinician group with access to the Enhanced Primary Care Diabetes model was found to improve their diabetes care quality.

Jaime Murillo, MD, discusses the impact of diabetes on cardiovascular disease.

Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE, leads a discussion surrouding early intervention in the management of type 2 diabetes.

A new study found that people with type 2 diabetes had improved glycemic control and weight when on a low-carbohydrate, high-fat diet compared with a high-carbohydrate, low-fat diet.

Patients with type 2 diabetes can determine their risk of chronic kidney disease (CKD) by using a risk prediction model.

Patients with chronic kidney disease (CKD), whether or not they also had diabetes, were found to have a reduced risk of hospitalization when they took dapagliflozin.

Giving patients who have or who may be at risk of type 2 diabetes default grocery orders with nutritional value promoted healthier foodstuff purchases.

Risk factors for type 2 diabetes and features associated with pancreatic severity were associated with the risk of diabetes in patients with chronic pancreatitis.

Different dietary approaches were able to improve the state of health in patients with type 2 diabetes (T2D), with very-low-calorie ketogenic diets demonstrating better results on gut microbiota profile.

Noninvasive methods of measuring blood glucose levels have demonstrated promise in early trials and could be potential replacements for glucose monitoring in the future, according to a review.

Producing insulin in state could help to lower the price for California residents with diabetes in the 3 years following implementation of the CalRx initiative.

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.

Patients with type 2 diabetes who use empagliflozin or sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2) long term were shown to have less kidney function loss.

A cross-sectional study found that fibrosis-4 index was linked to arterial damage and risk of coronary heart disease (CHD) in people with type 2 diabetes (T2D).

Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.